Liangliang Zhu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Escherichia Coli

Molecular Dynamics Simulations

Genetic Diversity

High Throughput

Top Venues

European journal of drug metabolism and pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Wenjing Li, Yufan Xue, Feng Zhang, Ling Xiao, Zhu Huang, Wenjuan Li, Liangliang Zhu, Guangbo Ge
In Vitro Ciclopirox Glucuronidation in Liver Microsomes from Humans and Various Experimental Animals. European journal of drug metabolism and pharmacokinetics 49 (5) (2024)
Wenjing Li, Yufan Xue, Feng Zhang, Ling Xiao, Zhu Huang, Wenjuan Li, Liangliang Zhu, Guangbo Ge
In Vitro Ciclopirox Glucuronidation in Liver Microsomes from Humans and Various Experimental Animals. European journal of drug metabolism and pharmacokinetics 49 (5) (2024)
Wenjing Li, Yufan Xue, Feng Zhang, Ling Xiao, Zhu Huang, Wenjuan Li, Liangliang Zhu, Guangbo Ge
In Vitro Ciclopirox Glucuronidation in Liver Microsomes from Humans and Various Experimental Animals. European journal of drug metabolism and pharmacokinetics (2024)
Wenjing Li, Yufan Xue, Feng Zhang, Ling Xiao, Zhu Huang, Wenjuan Li, Liangliang Zhu, Guangbo Ge
In Vitro Ciclopirox Glucuronidation in Liver Microsomes from Humans and Various Experimental Animals. European journal of drug metabolism and pharmacokinetics 49 (5) (2024)
Ling Xiao, Dehui Chi, Guiju Sheng, Wenjuan Li, Penghui Lin, Sicheng Liang, Liangliang Zhu, Peipei Dong
Inhibitory effects of UDP-glucuronosyltransferase (UGT) typical ligands against E. coli beta-glucuronidase (GUS). RSC advances 10 (39) (2020)